DEVICE · Unmapped registry intervention
Artemia
Find medicine records ·
Find other trials using this name
Clinical trial
MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer
NCT04320147
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedMR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
ArtemiaDEVICE
Sponsors & collaborators
Asan Medical Centerlead sponsor
Bumjin Limcollaborator
Dalsan Yoocollaborator
Hyung Keun Parkcollaborator
Jun Hyuk Hongcollaborator
Hanjong Ahncollaborator
Choung-Soo Kimcollaborator
Kye Jin Parkcollaborator
Mi-Hyun Kimcollaborator
Jeong Kon Kimcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04320147 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.